A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Partial EpilepsyCatamenial Epilepsy
Interventions
DRUG

Ganaxolone

Oral suspension 200-500 mg 3x/day

OTHER

Placebo

non-active placebo

Trial Locations (27)

12208

Neurosciences Institute at Albany Medical Center, Albany

13210

SUNY Upstate Medical University, Syracuse

19063

Riddle Health Care Center for Neuroscience, Media

19102

Drexel University / Hahneman Hospital, Philadelphia

19107

Thomas Jefferson University, Philadelphia

20817

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

23298

Virginia Commonwealth University, Richmond

30322

Emory HealthCare, Atlanta

34232

Intercoastal Medicine, Sarasota

37232

Vanderbilt University Medical Ctr, Nashville

40536

University of Kentucky, Dept. of Neurology, Lexington

43210

Ohio State University Medical Center, Columbus

48202

2799 West Grand blvd. CFP 071, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

62702

Southern Illinois University Medical Center, Springfield

63017

Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield

72205

Arkansas Epilepsy Program, Little Rock

75230

Neurological Clinic of Texas, P.A., Dallas

85013

Barrow Neurological Institute, Phoenix

90033

University of Southern California Adult Comprehensive Epilepsy Center, Los Angeles

95817

University of California-Davis, Sacramento

35294-0021

University of Alabama, Birmingham

80010-0045

Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital, Aurora

06520

Yale University School of Medicine, New Haven

32610-0236

University of Florida McKnight Brain Institute, Gainesville

55102-2383

Minnesota Epilepsy Group, PA, Saint Paul

07601

Overlook Hospital and Hackensack Medical Center, Hackensack

Sponsors
All Listed Sponsors
lead

Marinus Pharmaceuticals

INDUSTRY

NCT00465517 - A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures | Biotech Hunter | Biotech Hunter